510 results match your criteria: "IRCCS Neurological Institute "C. Mondino"[Affiliation]"

Global synergistic actions to improve brain health for human development.

Nat Rev Neurol

June 2023

World Federation of Neurosurgical Societies, Prague, Czech Republic.

Article Synopsis
  • Neurological disorders are a growing global issue, particularly in low-resource settings, highlighting the need for improved brain health services.
  • The World Health Organization's new plan emphasizes the importance of addressing these disorders for population well-being and economic growth, revealing a chance to enhance neurological care.
  • The proposed "neurological quadrangle" focuses on four main areas: surveillance, prevention, acute care, and rehabilitation, advocating for innovative strategies that include holistic approaches and equitable access to services for all people.
View Article and Find Full Text PDF

Introduction: The Performance of Upper Limb version 2.0 (PUL 2.0) is increasingly used in Duchenne Muscular Dystrophy (DMD) to study longitudinal functional changes of motor upper limb function in ambulant and non-ambulant patients.

View Article and Find Full Text PDF

Personality traits and dimensions of mental health.

Sci Rep

May 2023

Department of Brain and Behavioral Sciences, National Neurological Institute, IRCCS "C. Mondino" Foundation, Pavia, Italy.

Individuals are different in a relatively constant pattern of thoughts, feeling, and behaviors, which are called personality traits. Mental health is a condition of well-being in which people may reach their full potential and deal effectively with stress, work efficiently, and contribute to their communities. Indeed, the link between personality and mental health as indicated by the 12-item version of the general health questionnaires (GHQ-12) has been well-established according to evidence found by decades of research.

View Article and Find Full Text PDF
Article Synopsis
  • The study compares disability progression in primary progressive multiple sclerosis (PPMS) and secondary progressive multiple sclerosis (SPMS), revealing that SPMS has a later onset and slower disability accrual compared to PPMS.* -
  • Analysis utilized data from the MSBase cohort, adjusting for factors like age, sex, and drug therapies, and included 1,872 PPMS patients and 2,575 SPMS patients.* -
  • Findings suggest that although SPMS patients start with greater baseline disability, their slower progression may lead to similar disability levels over time, indicating the need for careful consideration when combining these groups in clinical trials.*
View Article and Find Full Text PDF

Understanding Cognitive Deficits in People with Coronary Heart Disease (CHD).

J Pers Med

February 2023

IRCCS "C. Mondino" Foundation, National Neurological Institute, Department of Brain and Behavioral Sciences, University of Pavia, 27100 Pavia, Italy.

Coronary heart disease (CHD) is one of the main cardiovascular diseases that can cause disability and death across the globe. Although previous research explored the links between CHD and cognitive deficits, only a subset of cognitive abilities was analyzed and a small clinical sample size was used. Thus, the aim of the current study is to assess how CHD can affect the cognitive domains of episodic memory, semantic verbal fluency, fluid reasoning, and numerical ability in a large cohort of participants from the United Kingdom.

View Article and Find Full Text PDF

The prediction of chronological age from methylation-based biomarkers represents one of the most promising applications in the field of forensic sciences. Age-prediction models developed so far are not easily applicable for forensic caseworkers. Among the several attempts to pursue this objective, the formulation of single-locus models might represent a good strategy.

View Article and Find Full Text PDF

Medication overuse headache.

Nat Rev Dis Primers

February 2023

Department of Neurology and Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.

Medication overuse headache (MOH) is a secondary headache disorder attributed to overuse of acute headache medications by a person with an underlying headache disorder, usually migraine or tension-type headache. MOH is common among individuals with 15 or more headache days per month. Although MOH is associated with substantial disability and reductions in quality of life, this condition is often under-recognized.

View Article and Find Full Text PDF

Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey.

Neurology

March 2023

From the Pediatric Neurology (Giorgia Coratti, M.R., A.C., M.C.P., M.D.P., E.M.), Università Cattolica del Sacro Cuore, Rome; Centro Clinico Nemo (Giorgia Coratti, M.R., A.C., M.C.P., M.D.P., E.M.), Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome; Department of Neurosciences (A.D.), Unit of Neuromuscular and Neurodegenerative Disorders, Bambino Gesù Children's Hospital, IRCCS, Rome; The NEMO Center in Milan (V.S.), Neurorehabilitation Unit, University of Milan, ASST Niguarda Hospital, Italy; Center of Translational and Experimental Myology (C.B.), and Department of Neuroscience, Rehabilitation, Ophtalmology, Genetics, Maternal and Child Health, University of Genova, IRCCS Istituto Giannina Gaslini; Department of Clinical and Experimental Medicine (S.M.), University of Messina; AOU Città della Salute e della Scienza di Torino (F.R., T.M.), presidio Molinette e OIRM (SS Malattie Neuromuscolari e SC Neuropsichiatria Infantile), Turin; Department of Neurological Sciences (M.C.), AOU Ospedali Riuniti di Ancona; AOU Pisana (Department of Clinical and Experimental Medicine) (G.S.), Neurology Unit, Pisa; Neurology Unit (E.P.), Azienda Ospedale Padova, Padua; Department of Neurology/Stroke Unit (M.T.), Bolzano Hospital, Trentino-Alto Adige; Department of Clinical and Experimental Sciences (M.F.), University of Brescia; NeMO-Brescia Clinical Center for Neuromuscular Diseases (M.F.), Brescia; Neurology Unit (Giacomo Comi), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan; Dino Ferrari Center (Giacomo Comi), Department of Pathophysiology and Transplantation, University of Milan; Fondazione IRCCS Istituto Neurologico Carlo Besta Developmental Neurology Unit (R.M.), Milan; Neuroimmunology and Neuromuscular Disorders Unit (L.M.), Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan; Institute for Maternal and Child Health (I.B.), IRCCS, Burlo Garofolo, Trieste; NeuroMuscular Unit (M.G.D.A.), Scientific Institute IRCCS E. Medea, Bosisio Parini, Lecco; Scientific Institute IRCCS "E. Medea" (A.T.), Unit for Severe disabilities in developmental Age and Young Adults (Developmental Neurology and Neurorehabilitation), Brindisi; UOC Clinica Neurologica (V.V.), IRCCS Institute of Neurological Sciences of Bologna, Emilia-Romagna; Metabolic Unit (M.D.), A. Meyer Children's Hospital, Florence; Neurology Unit (I.S.), Azienda Ospedaliero-Universitaria, Policlinico Bari "Amaducci", Bari; Department of Neurosciences (L.R.), Reproductive Sciences and Odontostomatology, University of Naples Federico II; Department of Neurosciences (A.V.), Pediatric Neurology, Santobono-Pausilipon Children's Hospital, Naples; Neurology Unit (L.V.), Department of Neurosciences, University Hospital Santa Maria della Misericordia, Udine, Friuli-Venezia Giulia; Department of Child Neuropsychiatry (A.B.), Fondazione Istituto Neurologico Nazionale C Mondino Istituto di Ricovero e Cura a Carattere Scientifico, Pavia; Dipartimento di Salute della Donna e del Bambino (C.A.), Università di Padova, Padua; IRCCS Istituto delleScienze Neurologiche di Bologna-UOC Neuropsichiatria Infantile (A.P.); Centro Sclerosi Multipla (M.A.M.), P.O. Binaghi, ASSL Cagliari; Cardiomyology and Medical Genetics Unit (L.P.), Università degli Studi della Campania Luigi Vanvitelli Scuola di Medicina e Chirurgia, Napoli; Section of Neurology (F.B.), Department of Biomedicine, Neuroscience, and Advanced Diagnostics (BiND), University of Palermo; Neurology Department (N.C.), Hospital San Francesco of Nuoro; Department of Neuroscience (M.G.), Mental Health and Sensory Organs (NESMOS), Sapienza University of Rome, Sant'Andrea Hospital; Neuromuscular Omnicentre (NeMO) Trento-Fondazione Serena Onlus (R.Z.), Pergine Valsugana; Pediatric Neurology Unit (D.G.), Pediatric Hospital "Giovanni XXIII", Bari; Child Neuropsychiatry Unit (S.S.), Paediatric Hospital G Salesi, Ancona; Institute of Experimental Neurology (INSPE), Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan; National Centre for Rare Diseases (D.T.), Istituto Superiore di Sanità, Rome; and Sezione di Igiene (S.B.), Istituto di Sanità Pubblica, Università Cattolica del Sacro Cuore, Rome, Italy.

Article Synopsis
  • - The study focuses on spinal muscular atrophy (SMA), a genetic neurodegenerative disorder, aiming to determine its prevalence and treatment rates in Italy.
  • - An online survey was conducted across 36 Italian referral centers, revealing 1,255 SMA patients with an estimated prevalence of 2.12 per 100,000 people, categorized by SMA type and severity.
  • - Around 85% of patients received treatment, but the percentage varied by severity, showing higher treatment rates in more severe cases (95.77% for type I compared to 79.01% for type III).
View Article and Find Full Text PDF

Insomnia affects one-third of the adult population and is associated with multiple medical conditions. We conducted an observational epidemiological survey to assess (1) the prevalence of insomnia in an Italian group of patients aged over 50 years, presenting directly to the general physician (GP); (2) the association of insomnia with sleepiness and comorbidities; and (3) the pharmacological treatment. The study was carried out by GPs.

View Article and Find Full Text PDF

Pain and agitation treatment in severe dementia patients: The need for Italian Mobilization-Observation-Behavior-Intensity-Dementia (I-MOBID2) pain scale translation, adaptation and validation with psychometric testing.

Biomed Pharmacother

June 2022

Pharmacotechnology Documentation and Transfer Unit, Preclinical and Translational Pharmacology, Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy. Electronic address:

The 97% of dementia patients develops fluctuant neuropsychiatric symptoms often related to under-diagnosed and unrelieved pain. Up to 80% severe demented nursing home residents experiences chronic pain due to age-related comorbidities. Patients lacking self-report skills risk not to be appropriately treated for pain.

View Article and Find Full Text PDF

Up to 80% of Alzheimer's disease (AD) patients in nursing homes experiences chronic pain and 97% develops fluctuant neuropsychiatric symptoms (NPS). Agitation, associated with unrelieved pain, is managed through antipsychotics and may increase the risk of death. Evidence is accumulating in favor of analgesia for a safer, effective therapy of agitation.

View Article and Find Full Text PDF

Purpose: Spinal cord gray-matter imaging is valuable for a number of applications, but remains challenging. The purpose of this work was to compare various MRI protocols at 1.5 T, 3 T, and 7 T for visualizing the gray matter.

View Article and Find Full Text PDF

Migraine is a major neurological disorder affecting one in nine adults worldwide with a significant impact on health care and socioeconomic systems. Migraine is more prevalent in women than in men, with 17% of all women meeting the diagnostic criteria for migraine. In women, the frequency of migraine attacks shows variations over the menstrual cycle and pregnancy, and the use of combined hormonal contraception (CHC) or hormone replacement therapy (HRT) can unveil or modify migraine disease.

View Article and Find Full Text PDF

Mutations in the RYR1 gene, encoding ryanodine receptor 1 (RyR1), are a well-known cause of Central Core Disease (CCD) and Multi-minicore Disease (MmD). We screened a cohort of 153 patients carrying an histopathological diagnosis of core myopathy (cores and minicores) for RYR1 mutation. At least one RYR1 mutation was identified in 69 of them and these patients were further studied.

View Article and Find Full Text PDF

Clinical-Genetic Features Influencing Disability in Spastic Paraplegia Type 4: A Cross-sectional Study by the Italian DAISY Network.

Neurol Genet

April 2022

Dipartimento di Neuroscienze Università Cattolica del Sacro Cuore, Facoltà di Medicina e Chirurgia, and Dipartimento di Scienze dell'Invecchiamento, Neurologiche, Ortopediche e della Testa-Collo, UOC Neurologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome (Salvatore Rossi, V.R., Gabriella Silvestri); IRCCS Fondazione Stella Maris (A.R., M.B., R.B., I.R., A.T., R.T., F.M.S.), Calambrone, Pisa; Laboratorio di Biologia Molecolare (M.T.B.), IRCCS E. Medea, Bosisio Parini, Lecco; Dipartimento di Medicina Clinica e Sperimentale (R.B.), Università di Pisa; Unità di Malattie Neuromuscolari e Neurodegenerative (E.B., F.N., L.T.), Laboratorio di Medicina Molecolare, Dipartimento di Neuroscienze, IRCCS Ospedale Pediatrico Bambino Gesù, Rome; Dipartimento della Donna (Cristina Cereda), della Mamma, del Neonato, ASST Fatebenefratelli Sacco, Ospedale dei Bambini "V. Buzzi," Milano; Dipartimento di Scienze e Biotecnologie medico-chirurgiche (E.C., V.G., Carlo Casali), Sapienza Università di Roma; Dipartimento di Neuroscienze (Chiara Criscuolo, A.F.), Scienze Riproduttive e Odontostomatologiche, Università Federico II, Napoli; Department of Advanced Medical and Surgical Sciences (I.O., S.S., M.A.B.M.), 2nd Division of Neurology, Center for Rare Diseases and InterUniversity Center for Research in Neurosciences, University of Campania "Luigi Vanvitelli," Naples, Italy; Dipartimento di Scienze del Sistema Nervoso e del Comportamento (B.D.F.), Fondazione Istituto Neurologico C. Mondino IRCCS, Pavia; U.O. Neurologia (C.D.), IRCCS Policlinico San Donato, Milano; Unità Operativa Patologie Neuromuscolari (M.G.D.A.), IRCCS E. Medea, Bosisio Parini, Lecco; Ospedale Clinicizzato "SS Annunziata" (A.D.M.), Università di Chieti; U.O. Neuro-Oncologia (L.D.), IRCCS Mondino Foundation, Pavia; Unit of Neurology and Neurometabolic Disorders (M.T.D., Andrea Mignarri), Department of Medicine, Surgery and Neurosciences, University of Siena, Siena; IRCCS Istituto delle Scienze Neurologiche di Bologna (R.L., G.R.); Dipartimento di Scienze Biomediche e Neuromotorie (R.L.), Università di Bologna; Dipartimento di Neuroriabilitazione, IRCCS Medea, Polo di Conegliano-Pieve di Soligo (Andrea Martinuzzi), Conegliano, Treviso; Unit Malattie Neuromuscolari (Roberto Massa), Policlinico and Università di Roma Tor Vergata; Direzione Scientifica (Rossana Moroni), Fondazione Policlinico A. Gemelli IRCCS, Rome; Dipartimento di Medicina Clinica e Sperimentale (O.M.) Università di Messina; Dipartimento di Neuroscienze e Salute Mentale (L.O.), SC Neurologia 1, A.O.U Città della Salute e della Scienza di Torino; Clinica Neurologica (E.P.), Dipartimento di Neuroscienze, Azienda Ospedale Università Padova; Centro Malattie Neuromuscolari e Neurologiche Rare (A.P.), A.O. San Camillo-Forlanini, Rome; Laboratorio di Genetica Molecolare e Citogenetica (M.P.), Fondazione Istituto Neurologico C. Mondino IRCCS, Pavia; Department of Neurosciences (Silvia Romano), Mental Health and Sensory Organs, Sapienza University of Rome; Laboratorio di Neurogenetica (R.R., A.O.), Centro Europeo di Ricerca Sul Cervello, IRCCS Fondazione Santa Lucia, Rome; Dipartimento di Neurologia (Marina Scarlato), IRCCS Ospedale San Raffaele; Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, and IRCCS Azienda Ospedaliero-Universitaria di Bologna (Marco Seri), Servizio di Genetica Medica, Bologna; IRCCS E. Medea, Pieve di Soligo, Treviso; Fondazione IRCCS Istituto Neurologico Carlo Besta (Giulia Straccia), Department of Clinical Neurosciences, Parkinson and Movement Disorders Unit, Milan, Italy; Dipartimento Salute Donna e Bambino (L.U.), S.S.D. di Genetica Clinica e Biologia dello Sviluppo, Azienda ospedaliero-universitaria di Sassari; Dipartimento di Biologia (G.V.), Università degli Studi di Padova; Dipartimento di Medicina e Chirurgia (A.O.), Università di Perugia; Dipartimento di Scienze dell'Invecchiamento (Gabriella Silvestri), Neurologiche, Ortopediche e della Testa-Collo, UOC Neurologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome; and Sbarro Institute for Cancer Research and Molecular Medicine (M.A.B.M.), Center for Biotechnology, Temple University, Philadelphia, PA.

Background And Objectives: Hereditary spastic paraplegias (HSPs) are a group of inherited rare neurologic disorders characterized by length-dependent degeneration of the corticospinal tracts and dorsal columns, whose prominent clinical feature is represented by spastic gait. Spastic paraplegia type 4 (SPG4, SPAST-HSP) is the most common form. We present both clinical and molecular findings of a large cohort of patients, with the aim of (1) defining the clinical spectrum of SPAST-HSP in Italy; (2) describing their molecular features; and (3) assessing genotype-phenotype correlations to identify features associated with worse disability.

View Article and Find Full Text PDF

MAGNIMS recommendations for harmonization of MRI data in MS multicenter studies.

Neuroimage Clin

May 2022

Section of Neuroradiology, Department of Radiology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.

Article Synopsis
  • There is a growing need to share standardized data from large studies to create new diagnostic and prognostic tools in multiple sclerosis (MS), particularly for integrating recent MRI advancements into clinical practice.
  • Variations in MRI parameters, analysis methods, and data storage across different research sites pose significant challenges for achieving consistency, which this review aims to address by highlighting current technical advances and future needs.
  • Collaborative efforts among specialized academic centers are essential for managing large MRI datasets effectively, ensuring personalized patient care in MS while optimizing resource use, and the review includes recommendations for overcoming existing hurdles.
View Article and Find Full Text PDF

Background And Purpose: A diagnostic score was developed to discriminate anti-myelin-associated-glycoprotein (MAG) neuropathy from chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and applied it to patients with atypical anti-MAG neuropathy.

Methods: The clinical and electrophysiological features of patients with a diagnosis of typical anti-MAG neuropathy were compared to those of patients with a diagnosis of CIDP. The association of each feature with the diagnosis was assessed in the two groups.

View Article and Find Full Text PDF
Article Synopsis
  • The study examined 276 Italian patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) for the presence of anti-nerve autoantibodies and correlated findings with clinical data.
  • Anti-neurofascin155 (NF155) and anti-contactin1 (CNTN1) antibodies were found in a small percentage of patients, with specific clinical symptoms linked to each type of antibody.
  • The presence of these antibodies suggests that CIDP may have various underlying mechanisms, leading to different clinical manifestations in patients.
View Article and Find Full Text PDF

DYT6 dystonia is caused by mutations in the transcription factor THAP1. THAP1 knock-out or knock-in mouse models revealed complex gene expression changes, which are potentially responsible for the pathogenesis of DYT6 dystonia. However, how THAP1 mutations lead to these gene expression alterations and whether the gene expression changes are also reflected in the brain of THAP1 patients are still unclear.

View Article and Find Full Text PDF

Pain is underdiagnosed and often not adequately treated, contributing to behavioral and psychological symptoms of dementia (BPSD). BPSD are treated with atypical antipsychotics that are associated with severe cerebrocardiovascular effects. Interestingly, treatment of pain may reduce agitation.

View Article and Find Full Text PDF

Background: Neurological immune-related adverse events (nirAEs) are rare toxicities of immune-checkpoint inhibitors (ICI). With the increase of ICI oncological indications, their incidence is growing. Their recognition and management remain nevertheless challenging.

View Article and Find Full Text PDF

The neurophysiological lesson from the Italian CIDP database.

Neurol Sci

January 2022

Department of Neuroscience, Reproductive Sciences and Odontostomatology, University of Naples 'Federico II', Via Pansini, 5, 81025, Naples, Italy.

Introduction: Electrophysiological diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) may be challenging. Thus, with the aim ofproviding some practical advice in electrophysiological approach to a patient with suspected CIDP, we analyzed electrophysiological data from 499 patients enrolled inthe Italian CIDP Database.

Methods: We calculated the rate of each demyelinating feature, the rate of demyelinating features per nerve, the diagnostic rate for upper andlower limb nerves, and, using a ROC curve analysis, the diagnostic accuracy of each couple of nerves and each demyelinating feature, for every CIDP subtype.

View Article and Find Full Text PDF

Archaeogenomic distinctiveness of the Isthmo-Colombian area.

Cell

April 2021

Department of Biology and Biotechnology "L. Spallanzani, " University of Pavia, Pavia 27100, Italy. Electronic address:

The recently enriched genomic history of Indigenous groups in the Americas is still meager concerning continental Central America. Here, we report ten pre-Hispanic (plus two early colonial) genomes and 84 genome-wide profiles from seven groups presently living in Panama. Our analyses reveal that pre-Hispanic demographic events contributed to the extensive genetic structure currently seen in the area, which is also characterized by a distinctive Isthmo-Colombian Indigenous component.

View Article and Find Full Text PDF

Objective: Few studies have examined lockdown effects on the way of living and well-being of older adults stratified by cognitive state. Since cognitive deficits are common in this population, we investigated how cognition influenced their understanding of the pandemic, socio-behavioral responses and lifestyle adaptations during lockdown, and how these factors affected their mood or memory.

Method: Telephone-based survey involving 204 older adults ≥65 y/o (median: 82) with previous assessments of cognitive state: 164 normal-old (NOLD), 24 mild-neurocognitive disorder (mild-NCD), 18 mild-moderate dementia.

View Article and Find Full Text PDF